# US 11,110,293 B2 · Phototherapy systems and methods of phototherapy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 11,110,293 B2
- Document ID: US11110293B2
- Status: Granted
- Kind: B2
- Application number: 16/240,585
- Filed: 2019-01-04
- Published: 2020-07-09
- Granted: 2021-09-07
- Earliest claimed: 2019-01-04
- Assignees: L'oreal
- Applicants: L'Oreal
- Inventors: Geoffrey F. Deane; Lily Truong; Zane Bowman Allen Miller
- Web page: https://patentgrep.com/patent/US11110293B2

## CPC

- A61N 5/0616: {Skin treatment other than tanning}
- A61N 5/0622: {Optical stimulation for exciting neural tissue}
- A61N 2005/0626: {Monitoring, verifying, controlling systems and methods}
- A61N 2005/065: {Light sources therefor}
- A61N 2005/0662: {Visible light}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

Phototherapy systems and methods of phototherapy are described. In an example, the phototherapy system includes a therapeutic light source configured to emit phototherapeutic light towards a subject; and a placebo light source configured to emit placebo light towards the subject. In an embodiment, the light, including the phototherapeutic light and the placebo light, emitted by the phototherapy system is configured to be visually perceived by the subject as continuous light. In an embodiment, the placebo light is a metameric match of the phototherapeutic light. In an embodiment, the method includes emitting the placebo light in a wavelength range and at an intensity configured to be visually perceived by the user as the phototherapeutic light, such as where the placebo light is a metameric match of the phototherapeutic light.

## Claims

### Claim 1

A phototherapy system comprising:
a therapeutic light source configured to emit phototherapeutic light towards a subject;
a placebo light source configured to emit placebo light towards the subject, the placebo light source including a first placebo light source configured to emit first placebo light and a second placebo light source configured to emit second placebo light; and
a controller operatively coupled to the therapeutic light source and the placebo light source, the controller including instructions that, when executed by the controller, cause the phototherapy system to perform operations including:
emitting the phototherapeutic light from the therapeutic light source as a plurality of phototherapeutic light pulses; and
emitting the placebo light from the placebo light source as a plurality of placebo light pulses in a wavelength range that is a metameric match of the phototherapeutic light and at an intensity configured to be visually perceived by the user as the phototherapeutic light,
wherein the phototherapy system is configured to emit light, including the phototherapeutic light and the placebo light, that is configured to be visually perceived by the subject as continuous light,
wherein one or more of the plurality of placebo light pulses are interspersed between phototherapeutic light pulses of the plurality of phototherapeutic light pulses,
wherein emitting the placebo light from the placebo light source includes:
emitting the first placebo light in a first wavelength range; and
emitting the second placebo light in a second wavelength range different from the first wavelength range, and
wherein a combination of the first placebo light and the second placebo light provides the metameric match between the phototherapeutic light and the placebo light.

### Claim 2 (depends on 1)

The phototherapy system of claim 1, wherein the placebo light includes visible light.

### Claim 3 (depends on 1)

The phototherapy system of claim 1, wherein the controller includes instructions that, when executed by the controller, cause the phototherapy system to perform operations including:
emitting the phototherapeutic light and the placebo light during common active periods of time; and
not emitting the phototherapeutic light and the placebo light during common inactive periods of time.

### Claim 4

A method of phototherapy comprising:
emitting phototherapeutic light including a plurality of phototherapeutic light pulses from a phototherapeutic light source onto a portion of a subject; and
emitting placebo light including emitting a plurality of placebo light pulses from a placebo light source for visual receipt by the subject, wherein the placebo light is in a wavelength range that is a metameric match of the phototherapeutic light and at an intensity configured to be visually perceived by the user as the phototherapeutic light;
wherein combined light including the phototherapeutic light and the placebo light is configured to be perceived by the subject as continuous light,
wherein one or more of the plurality of placebo light pulses are interspersed between phototherapeutic light pulses of the plurality of phototherapeutic light pulses,
wherein emitting the placebo light from the placebo light source includes:
emitting first placebo light in a first wavelength range; and
emitting second placebo light in a second wavelength range different from the first wavelength range, and
wherein a combination of the first placebo light and the second placebo light provides the metameric match between the phototherapeutic light and the placebo light.

### Claim 5 (depends on 4)

The method of claim 4, wherein the placebo light includes visible light.

### Claim 6 (depends on 4)

The method of claim 4, wherein emitting the phototherapeutic light and emitting the placebo light includes:
emitting the phototherapeutic light and the placebo light during common active periods of time; and
not emitting the phototherapeutic light and the placebo light during common inactive periods of time.